Howard W. Robin
About Howard W. Robin
Howard W. Robin is the President and CEO of Nektar Therapeutics, with over 25 years of experience in biopharmaceutical clinical development and commercial operations.
Howard W. Robin: President & CEO of Nektar Therapeutics
Howard W. Robin has served as President and CEO of Nektar Therapeutics, a biopharmaceutical company, since January 2007. With over 25 years in the biopharmaceutical sector, Robin brings extensive experience in managing both clinical development and commercial operations. Under his leadership, Nektar Therapeutics focuses on developing novel therapeutics for various diseases.
Howard W. Robin's Tenure at Sirna Therapeutics
Before joining Nektar Therapeutics, Howard W. Robin was the President and CEO of Sirna Therapeutics, a clinical-stage biotechnology company. At Sirna, Robin successfully re-launched the company, significantly enhancing its value, which culminated in its acquisition by Merck for $1.1 billion. Sirna Therapeutics was known for pioneering RNAi-based therapies targeting serious diseases and conditions.
Howard W. Robin’s Career at Berlex Laboratories
Howard W. Robin spent 20 years at Berlex Laboratories, serving as Corporate Vice President and General Manager of the U.S. Therapeutics division from 1991 to 2001. He played a key role in developing drugs such as Betaseron for multiple sclerosis and Fludara for chronic lymphocytic leukemia. These drugs achieved annual global sales exceeding $800 million. Robin also held positions as Vice President of Finance and Business Development and CFO at Berlex.
Howard W. Robin's Early Career and Educational Background
Howard W. Robin began his career as a Senior Associate with Arthur Andersen and Co. He holds a B.S. in Accounting and Finance from Fairleigh Dickinson University in New Jersey. He serves on the Board of Trustees at Fairleigh Dickinson University, supporting its mission and contributing to its growth and success.
Howard W. Robin's Role in the Biotechnology Industry Organization
In addition to his corporate roles, Howard W. Robin serves as a director of the Biotechnology Industry Organization, the world's largest biotechnology industry trade organization. This position enables him to influence policy and advocate for the biotechnology sector at a global level.